Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Period 1	STARTED	Sildenafil / Sildenafil	89
Period 1	STARTED	Placebo / Sildenafil	91
Period 1	COMPLETED	Sildenafil / Sildenafil	81
Period 1	COMPLETED	Placebo / Sildenafil	85
Period 1	NOT COMPLETED	Sildenafil / Sildenafil	8
Period 1	NOT COMPLETED	Placebo / Sildenafil	6
Period 2	STARTED	Sildenafil / Sildenafil	79
Period 2	STARTED	Placebo / Sildenafil	83
Period 2	COMPLETED	Sildenafil / Sildenafil	73
Period 2	COMPLETED	Placebo / Sildenafil	70
Period 2	NOT COMPLETED	Sildenafil / Sildenafil	6
Period 2	NOT COMPLETED	Placebo / Sildenafil	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00517933/flow